1983•PubMedRequires access

Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.

I. Bodrogi, M. Baki, I. Hindy, Sabine Eckhardt

Abstract

Fifty-seven patients with testicular tumors have been treated with combined chemotherapy (vinblastine, bleomycin and cisplatinum). By evaluation of therapeutic activity and toxic effects it was shown that Platidiam, Lachema, effectivity was identical with the two other cisplatinum preparations used in this study.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Vinblastine, Bleomycin, Testicular cancer, Cisplatin, Medicine, Chemotherapy, Oncology, Urology